FI903464A0 - Foerfarande foer oxiderande denaturering av proteinanalyter. - Google Patents

Foerfarande foer oxiderande denaturering av proteinanalyter.

Info

Publication number
FI903464A0
FI903464A0 FI903464A FI903464A FI903464A0 FI 903464 A0 FI903464 A0 FI 903464A0 FI 903464 A FI903464 A FI 903464A FI 903464 A FI903464 A FI 903464A FI 903464 A0 FI903464 A0 FI 903464A0
Authority
FI
Finland
Prior art keywords
protein
proteinanalyter
oxiderande
denaturering
foerfarande foer
Prior art date
Application number
FI903464A
Other languages
English (en)
Finnish (fi)
Inventor
James Elting
Heinz Koelbl
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of FI903464A0 publication Critical patent/FI903464A0/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI903464A 1989-07-10 1990-07-09 Foerfarande foer oxiderande denaturering av proteinanalyter. FI903464A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/377,680 US5061790A (en) 1989-07-10 1989-07-10 Oxidative denaturation of protein analytes

Publications (1)

Publication Number Publication Date
FI903464A0 true FI903464A0 (fi) 1990-07-09

Family

ID=23490110

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903464A FI903464A0 (fi) 1989-07-10 1990-07-09 Foerfarande foer oxiderande denaturering av proteinanalyter.

Country Status (18)

Country Link
US (1) US5061790A (ko)
EP (1) EP0407813B1 (ko)
JP (1) JP2915970B2 (ko)
KR (1) KR910003380A (ko)
AT (1) ATE147167T1 (ko)
AU (1) AU633115B2 (ko)
CA (1) CA2019671C (ko)
DE (1) DE69029540T2 (ko)
DK (1) DK0407813T3 (ko)
ES (1) ES2095847T3 (ko)
FI (1) FI903464A0 (ko)
GR (1) GR3022906T3 (ko)
IE (1) IE902493A1 (ko)
IL (1) IL94993A (ko)
NO (1) NO902833L (ko)
NZ (1) NZ234396A (ko)
PT (1) PT94633B (ko)
ZA (1) ZA905360B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740223B1 (fr) * 1995-10-19 1997-11-14 Commissariat Energie Atomique Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
DE69940805D1 (de) 1998-01-31 2009-06-10 Sinai School Medicine Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
WO2001066136A2 (en) * 2000-04-06 2001-09-13 Panacea Pharmaceuticals, Llc. Microbial delivery system
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
WO2003002908A1 (en) * 2000-06-26 2003-01-09 Reveo, Inc. Backlight for a liquid crystal display having high light-recycling efficiency
DE10054055A1 (de) 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US9557325B2 (en) * 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
US7892751B2 (en) * 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
CN1832756A (zh) * 2003-06-09 2006-09-13 约翰·A·麦金太尔 通过氧化还原反应改变血浆蛋白质结合专一性的方法
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
CA2680339C (en) * 2007-03-08 2017-02-28 F. Hoffmann-La Roche Ag Use of slim-1 in the assessment of heart failure
KR101322247B1 (ko) * 2007-09-06 2013-10-25 삼성전자주식회사 진공청소기용 흡입브러시 및 그 높이조절방법
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
US20130189707A1 (en) * 2010-01-26 2013-07-25 Svetlana Alexandrovna Sergeeva Method of determination of autoantibody level by means of enzyme immunoassay
WO2013116260A1 (en) * 2012-02-02 2013-08-08 Perfinity Biosciences, Inc. Selector based recognition and quantification system and method for multiple analytes in a single analysis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448530C3 (de) * 1974-10-11 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides

Also Published As

Publication number Publication date
ATE147167T1 (de) 1997-01-15
ZA905360B (en) 1991-04-24
DE69029540D1 (de) 1997-02-13
JPH0368868A (ja) 1991-03-25
AU5872790A (en) 1991-01-10
PT94633A (pt) 1991-03-20
KR910003380A (ko) 1991-02-27
CA2019671A1 (en) 1991-01-10
NO902833L (no) 1991-01-11
EP0407813A2 (en) 1991-01-16
AU633115B2 (en) 1993-01-21
US5061790A (en) 1991-10-29
ES2095847T3 (es) 1997-03-01
IL94993A0 (en) 1991-06-10
GR3022906T3 (en) 1997-06-30
IE902493A1 (en) 1991-02-13
NO902833D0 (no) 1990-06-26
NZ234396A (en) 1992-02-25
CA2019671C (en) 2002-08-13
EP0407813B1 (en) 1997-01-02
DE69029540T2 (de) 1997-05-07
EP0407813A3 (en) 1992-11-25
PT94633B (pt) 1997-04-30
DK0407813T3 (da) 1997-06-16
JP2915970B2 (ja) 1999-07-05
IL94993A (en) 1994-05-30

Similar Documents

Publication Publication Date Title
FI903464A0 (fi) Foerfarande foer oxiderande denaturering av proteinanalyter.
ES2059719T3 (es) Mejoras relativas a anticuerpos.
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
DE58904713D1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
PT93178A (pt) Agente proteico anticanceroso
ATE2049T1 (de) Mittel zur therapie von immunkomplexerkrankungen.
ES2053704T3 (es) Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.
ATE110774T1 (de) Gegen menschliches fibrinopepid a spezifische monoklonale antikörper.
ATE51520T1 (de) Kosmetikum.
DK447784A (da) Immuninterferon
ATE127849T1 (de) Immunologische vermehrung des somatogenischen effekts von somatotropin mit einem antikörper.
FI840949A (fi) Toxiner och antikroppar av mikro- organismen c.difficile.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: MOLECULAR DIAGNOSTICS, INC.